Evidence map›Paper›PMID 11032027›Full record

ArticleOncogene2000

Differential regulation of human RecQ family helicases in cell transformation and cell cycle.

T Kawabe, N Tsuyama, S Kitao, K Nishikawa, A Shimamoto, M Shiratori, T Matsumoto, K Anno, T Sato, Y Mitsui and 7 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 123 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Specific Monitoring the DNA Helicase Function via Anchor-Embedded DNA Probe.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. Article
  6. Review
  7. RecQ Helicase Somatic Alterations in Cancer.Frontiers in molecular biosciences · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

T KawabeAGENE Research Institute, Kamakura, Kanagawa, Japan.
N Tsuyama
S Kitao
K Nishikawa
A Shimamoto
M Shiratori
T Matsumoto
K Anno
T Sato
Y Mitsui
M Seki
T Enomoto
M Goto
N A Ellis
T Ide
Y Furuichi
M Sugimoto
GeneCare Research Institute (Japan) · JPHiroshima University · JPTohoku University · JPMemorial Sloan Kettering Cancer Center · USNational Institute of Advanced Industrial Science and Technology · JPOtsuka (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three human RecQ DNA helicases, WRN, BLM and RTS, are involved in the genetic disorders associated with genomic instability and a high incidence of cancer. RecQL1 and RecQL5 also belong to the human RecQ helicase family, but their correlation with genetic disorders, if any, is unknown. We report here that in human B cells transformed by Epstein-Barr virus (EBV), human fibroblasts and umbilical endothelial cells transformed by simian virus 40, the expression of WRN, BLM, RTS and RecQL1 was sharply up-regulated. In B cells this expression was stimulated within 5-40 h by the tumor promoting agent phorbol myristic acetate (PMA). Interestingly, RecQL5beta, an alternative splicing product of RecQL5 with a nuclear localization signal, is expressed in resting B cells without significant modulation of its synthesis by EBV or PMA, suggesting it has a role in resting cells. We also roughly determined the number of copies per cell for the five RecQ helicase in B cells. In addition, levels of the different RecQ helicases are modulated in different ways during the cell cycle of actively proliferating fibroblasts and umbilical endothelial cells. Our results support the view that the levels of WRN, BLM, RTS and RecQL1 are differentially up-regulated to guarantee genomic stability in cells that are transformed or actively proliferating.

Indexed as

Gene Expression Regulation, EnzymologicAdenosine TriphosphatasesAlternative SplicingB-LymphocytesCell CycleCell DivisionCell Line, TransformedCell Transformation, ViralDNA HelicasesEndothelium, VascularEnzyme InductionExodeoxyribonucleasesFibroblastsGene Expression Regulation, NeoplasticHerpesvirus 4, HumanHumansAdenosine TriphosphatasesBloom syndrome proteinDNA HelicasesExodeoxyribonucleasesRecQ HelicasesRECQL4 protein, humanTetradecanoylphorbol AcetateWerner Syndrome HelicaseWRN protein, human

Identifiers

PMID11032027
OpenAlexW2060329343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.